https://www.theepochtimes.com/epochtv/100-percent-cancer-remission-of-patients-in-monoclonal-antibody-trial-facts-matter-5620254?utm_source=Enews&utm_campaign=etv1-2024-04-03&utm_medium=email&est=AAAAAAAAAAAAAAAAa%2Bc5ZwpCztPd4LIuuWhYArg0yEwD%2BTwvt3acngPVaRuLrk%2FaLA%3D%3D
From the original study:
The immunotherapy I took, Keytruda (pembrlizumab), is also a monclonal antibody which also works on the PD-1 pathway.
Small study but, eesh, 12 out of 12 complete clinical response. Also, this was limited to "A subset of rectal cancer is caused by a deficiency in mismatch repair.", whatever that means.
Still, very promising.